期刊文献+

白介素-1受体拮抗剂对致敏豚鼠的抗喘作用(英文)

Anti-asthmatic effects of interleukin-1 receptor antagonist in sensitized guinea pigs
下载PDF
导出
摘要 目的 :观察白介素 1受体拮抗剂 (IL 1ra)对致敏豚鼠的抗喘作用。方法 :用卵白蛋白致敏豚鼠 ,用张力换能器和MedLab软件记录气道平滑肌的肌张力和收缩活动。结果 :整体实验时 ,在 0 .3 3~9.0mg·kg- 1 剂量范围内 ,IL 1ra能使组胺 乙酰胆碱及卵白蛋白诱发的致敏豚鼠哮喘的潜伏期延长 ,动物跌倒率降低。此作用具有剂量依赖性。其中 ,9.0mg·kg- 1 剂量组的作用与异丙基肾上腺素相同 ;离体实验时 ,3× 1 0 - 7mol·L- 1 以上浓度的IL 1ra对气管平滑肌具有直接松弛作用 ,其EC50 为 5 .88×1 0 - 7mol·L- 1 ;1 0 - 7mol·L- 1 的IL 1ra能对抗卵白蛋白引起的气管平滑肌肌张力的增加 ;3×1 0 - 7mol·L- 1 以上剂量组的IL 1ra预防给药则能使卵白蛋白诱发的气管平滑肌的收缩程度显著降低 ,其IC50 为 4.48× 1 0 - 7mol·L- 1 。结论 :IL 1ra能直接松弛致敏豚鼠的气管平滑肌 ,拮抗多种抗原诱发的致敏豚鼠的哮喘发作。 AIM: To observe the anti asthmatic effects of interleukin 1 receptor antagonist (IL 1ra) in sensitized guinea pigs. METHODS: Sensitized guinea pigs were made by ovalbumin, and the tension and contraction of tracheal smooth muscles were measured by force displacement transducer and MedLab software. RESULTS: In the doses of 0.33 - 9.0 mg·kg -1 , IL 1ra prolonged the asthmatic incubation period and reduced animal tumble ratio in asthma guinea pigs induced by histamine acetylcholine or ovalbumin. These effects were dose dependent. In vitro, IL 1ra could directly relax tracheal smooth muscles up the dose of 3×10 -7 mol·L -1 and the EC 50 value was 5.88 ×10 -7 mol·L -1 . IL 1ra antagonized the increase of trachea tension stimulated by ovalbumin at the dose of 10 -7 mol·L -1 . Moreover, IL-1ra prevented tracheal smooth muscle contraction induced by ovalbumin up the dose of 3×10 -7 mol·L -1 , and the IC 50 value was 4.48 ×10 -7 mol·L -1 . CONCLUSIONS: IL 1ra can directly relax tracheal smooth muscles in sensitized guinea pigs, and antagonize asthma caused by many kinds of antigens.
出处 《中国临床药理学与治疗学》 CAS CSCD 2003年第5期506-510,共5页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 863NationalNaturalScienceFoundationofChina(№ 2 0 0 1AA2 152 51)
关键词 药理学 白介素-1 受体拮抗剂 豚鼠 组胺 乙酰胆碱 卵白蛋白 哮喘 pharmacology interleukin 1 receptor antagonist histamine acetylcholine asthma contraction guinea pigs
  • 相关文献

参考文献20

  • 1[1]Peter JB. Cytokine modulators as novel therapies for asthma[ J].Annu Rev Pharmacol Toxicol, 2002; 42: 81 - 98
  • 2[2]Hakonarson H, Halapi E, Whelan R. Association between IL-1 beta/TNF-alpha-induced glucocorticoid-sensitive changes in multiple gene expression and altered responsiveness in airway smooth muscle[ J]. Am J Respir Cell Mol Boil, 2002; 25: 761 -71
  • 3[3]Amici DM, Puggioni F, Casali L. Variations in serum levels of interleukin (Il)-1beta, Il-2, Il-6, and tumor necrosis factor-alpha during specific immunotherapy[ J]. Ann Allergy Asthna Immunol, 2001 ;86:311 - 3
  • 4[4]Tillie-Leblond I, Pugin J, Marquette CH. Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus[J]. Am J Reapir Crit Care Med, 1999; 159:487 - 94
  • 5[5]Mao XQ, Kawai M, Yamashita T. Imbalance production between interleukin- 1 bata ( IL- 1 beta) and IL- 1 receptor antagonist (IL-1ra) in bronchial asthma[J]. Biochem Biophys Res Commun, 2000;276:607- 12
  • 6[6]Rosenwasser LJ. New immunopharmacologic approaches to asthma: role of cytokine antagonism [ J ]. J Allergy Clin Immunol,2000; 105: S586 - 91
  • 7[7]Ricci M, Matucci A, Rossi O. New advances in the pathogenesis and therapy of bronchial asthma[J]. Ann Ital Med Int, 1998;13:93- 110
  • 8[8]Hagaman DD, Okayama Y, D' Ambrosio C. Secretion of interleukin-1 receptor antagonist from human mast cells after immunoglobulin E-mediated activation and after segmental antigen challenge[J]. Am J Respir Cell Mol boil, 2001 ;25:685 -91
  • 9[9]Bjornsdottir US, Cypcar DM. Asthma: an inflammatory mediator soup[J]. Allergy, 1999;54:55- 61
  • 10[10]Stassen M, Arnold M, Hultner L, et al. Murine bone marrowderived mast cells as potent producers of IL-9: costimulatory function of IL- 1 0 and kit ligand in the presence of IL- 1 [ J ]. J Immunol, 2000; 164:5549 - 55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部